AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
Clevecord market forecast points to steady growth through 2035
AGP
The Business Research Company says the Clevecord market is set for steady expansion through 2035 as stem cell therapies, healthcare spending and aging populations increase demand.
Crosseal market seen growing on surgery demand, injuries and regional expansion
AGP
The Business Research Company says the Crosseal market is set for long-term growth as more surgeries, injury cases and minimally invasive procedures increase demand for fibrin sealants.
Cutaquig market seen growing as home infusion and immune disorder diagnoses rise
AGP
The market for Cutaquig, a subcutaneous immunoglobulin therapy for primary immunodeficiency, is expanding on rising diagnosis rates, wider use of home-based care and more infectious and age-related immune disorders.
Cervarix market seen growing on HPV prevention demand
AGP
The Business Research Company says the Cervarix vaccine market is poised for continued growth through 2035 as HPV awareness rises, immunization programs expand and cervical cancer prevention efforts intensify.
Crofab market study points to steady growth, led by North America
AGP
The Business Research Company says the Crofab market is expanding as snakebite cases, emergency care demand and healthcare spending rise.
Creon market seen growing on pancreatic disease burden and personalized care
AGP
The Creon market is projected to expand as pancreatic disorders rise, healthcare spending increases and personalized medicine gains ground.
Cyramza market seen rising to $1.79 million by 2030
AGP
The market for Cyramza (ramucirumab) is projected to grow from $1.31 million in 2025 to $1.79 million by 2030, driven by cancer prevalence, aging populations and broader use in oncology.
Crysvita market growth forecast tied to rare disease diagnostics and personalized medicine
AGP
The Business Research Company says the Crysvita market is expanding as rare disease screening, personalized medicine, and broader reimbursement support treatment for X-linked hypophosphatemia.
Cosentyx market seen growing to $8.74 million by 2030
AGP
The Business Research Company says the global Cosentyx drug market is expanding as autoimmune disease rates rise and biologic use widens.
LR warns ports are lagging alternative-fuel ship orders
AGP
Lloyd’s Register says alternative-fuel vessel orders are growing faster than the port infrastructure needed to bunker them, especially for methanol and ammonia.
Five Chinese custom toothbrush makers highlighted for 2026
AGP
A 2026 industry reference list spotlights five Chinese toothbrush manufacturers serving OEM, ODM and private-label buyers as global demand for customized oral care products grows.
Bageterie Boulevard opens franchise push beyond Central Europe
AGP
Bageterie Boulevard has launched an international franchise development program to take its European fast-casual concept into new markets after more than 23 years of refinement.
Biodiesel market seen topping $82B by 2030 as Western Europe, US lead growth
AGP
The Business Research Company says the global biodiesel market will exceed $82 billion by 2030, driven by blending mandates, low-carbon fuel demand and capacity expansions in renewable fuels.
Bravelle market set for growth as infertility and IVF demand rise
AGP
The Business Research Company says the global Bravelle market is expanding on rising infertility rates, wider IVF use and growing demand for personalized fertility care.
Apoptosis assay kit market seen growing to $12.02 billion by 2030
AGP
The apoptosis assay kit market is projected to rise from $6.91 billion in 2025 to $12.02 billion by 2030, according to The Business Research Company.
Arthralgia market seen reaching $8.26 billion by 2030
AGP
The global arthralgia market is projected to grow from $6.09 billion in 2026 to $8.26 billion by 2030, driven by rising joint disease cases, broader treatment options and more interest in personalized pain care.
Aquatic veterinary market seen reaching $1.94 billion by 2030
AGP
The aquatic veterinary market is projected to grow from $1.56 billion in 2025 to $1.94 billion by 2030 as aquaculture expands and disease prevention becomes more important.
Arteriovenous malformations market seen reaching $4.37B by 2030
AGP
The arteriovenous malformations market is projected to grow from $3.1 billion in 2025 to $4.37 billion by 2030, driven by minimally invasive treatment adoption, better diagnostics and rising biotech investment.
AR/VR medical simulation market seen reaching $8.94 billion by 2030
AGP
The AR/VR medical simulation market is projected to nearly double from 2026 levels and reach $8.94 billion by 2030, according to a new report from The Business Research Company.
Appendicitis treatment market seen reaching $5.97 billion by 2030
AGP
The appendicitis treatment market is projected to grow from $4.35 billion in 2025 to $4.63 billion in 2026, then reach $5.97 billion by 2030, according to The Business Research Company.
Sign up for:
The Europe Daily Report
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.